AbbVie today announced the 2022-2023 class of recipients of the AbbVie Immunology Scholarship, which provides financial support to students living with chronic, immune-mediated diseases pursuing higher education in the United States. As part of AbbVie’s leadership and commitment to the immunology community, the scholarship seeks to empower students as they pursue a degree and a life not defined by their diseases.
This year, AbbVie awarded scholarships to 45 recipients after receiving more than 1,000 applications from students with diverse backgrounds, perspectives and disease experiences throughout the U.S. Qualified applicants were selected based on academic performance, their ability to serve as a positive role model in their community, essay submission and recommendation letter.
“The AbbVie Immunology Scholarship will help me carve a path forward and expand my career in healthcare management while living with ankylosing spondylitis and supporting my young family,” said Alaa-adeen Ahmad, 2022-2023 scholarship recipient and Capella University student. “With my doctorate degree, I hope to become a healthcare quality and safety manager so that I can make a difference by improving the patient experience and helping others within the community.”
AbbVie is committed to transforming patients’ lives, so they can have the opportunity to live a life unhindered by their chronic, immune-mediated conditions. Since launching in 2016, the AbbVie Immunology Scholarship has helped more than 300 students living with chronic, immune-mediated diseases pursue higher education in the U.S. To see a list of 2022-2023 AbbVie Immunology Scholarship recipients, visit www.AbbVieImmunologyScholarship.com.
Students living with diseases across dermatology, gastroenterology and rheumatology and seeking an associate, bachelor’s, master’s or doctorate degree are eligible to apply for the scholarship. Those interested in applying for the 2023-2024 AbbVie Immunology Scholarship starting in October 2022 can sign up here to be notified when the application period opens.